These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21341275)

  • 21. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
    Li F; Bronson S; Niyibizi C
    J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The increase of pericyte population in human neuromuscular disorders supports their role in muscle regeneration in vivo.
    Díaz-Manera J; Gallardo E; de Luna N; Navas M; Soria L; Garibaldi M; Rojas-García R; Tonlorenzi R; Cossu G; Illa I
    J Pathol; 2012 Dec; 228(4):544-53. PubMed ID: 22847756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myogenic specification of side population cells in skeletal muscle.
    Asakura A; Seale P; Girgis-Gabardo A; Rudnicki MA
    J Cell Biol; 2002 Oct; 159(1):123-34. PubMed ID: 12379804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of Equine-Induced Pluripotent Stem Cells and Analysis of Their Therapeutic Potential for Muscle Injuries.
    Lee EM; Kim AY; Lee EJ; Park JK; Park SI; Cho SG; Kim HK; Kim SY; Jeong KS
    Cell Transplant; 2016 Nov; 25(11):2003-2016. PubMed ID: 27226077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new look at the origin, function, and "stem-cell" status of muscle satellite cells.
    Seale P; Rudnicki MA
    Dev Biol; 2000 Feb; 218(2):115-24. PubMed ID: 10656756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Satellite cells from dystrophic (mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers.
    Yablonka-Reuveni Z; Anderson JE
    Dev Dyn; 2006 Jan; 235(1):203-12. PubMed ID: 16258933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of deltaCaMKII isoforms in skeletal muscle regeneration: Implications in dystrophic muscle disease.
    Abraham ST; Shaw C
    J Cell Biochem; 2006 Feb; 97(3):621-32. PubMed ID: 16215994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
    Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
    Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.
    Lian Q; Zhang Y; Zhang J; Zhang HK; Wu X; Zhang Y; Lam FF; Kang S; Xia JC; Lai WH; Au KW; Chow YY; Siu CW; Lee CN; Tse HF
    Circulation; 2010 Mar; 121(9):1113-23. PubMed ID: 20176987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.
    Magli A; Incitti T; Perlingeiro RC
    Methods Mol Biol; 2016; 1460():191-208. PubMed ID: 27492174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
    Nishiyama T; Takeda S
    Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional myogenic engraftment from mouse iPS cells.
    Darabi R; Pan W; Bosnakovski D; Baik J; Kyba M; Perlingeiro RC
    Stem Cell Rev Rep; 2011 Nov; 7(4):948-57. PubMed ID: 21461712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.
    Torrente Y; Camirand G; Pisati F; Belicchi M; Rossi B; Colombo F; El Fahime M; Caron NJ; Issekutz AC; Constantin G; Tremblay JP; Bresolin N
    J Cell Biol; 2003 Aug; 162(3):511-20. PubMed ID: 12885758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor improves the muscle regeneration capacity of muscle stem cells in dystrophic muscle.
    Lavasani M; Lu A; Peng H; Cummins J; Huard J
    Hum Gene Ther; 2006 Feb; 17(2):180-92. PubMed ID: 16454652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
    Smith J; Goldsmith C; Ward A; LeDieu R
    Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy.
    Tedesco FS; Gerli MF; Perani L; Benedetti S; Ungaro F; Cassano M; Antonini S; Tagliafico E; Artusi V; Longa E; Tonlorenzi R; Ragazzi M; Calderazzi G; Hoshiya H; Cappellari O; Mora M; Schoser B; Schneiderat P; Oshimura M; Bottinelli R; Sampaolesi M; Torrente Y; Broccoli V; Cossu G
    Sci Transl Med; 2012 Jun; 4(140):140ra89. PubMed ID: 22745439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells.
    Filareto A; Parker S; Darabi R; Borges L; Iacovino M; Schaaf T; Mayerhofer T; Chamberlain JS; Ervasti JM; McIvor RS; Kyba M; Perlingeiro RC
    Nat Commun; 2013; 4():1549. PubMed ID: 23462992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal myogenesis by human primordial germ cell-derived progenitors.
    Shao H; Chen B; Tao M
    Biochem Biophys Res Commun; 2009 Jan; 378(4):750-4. PubMed ID: 19071088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior.
    Morosetti R; Gidaro T; Broccolini A; Gliubizzi C; Sancricca C; Tonali PA; Ricci E; Mirabella M
    Cell Transplant; 2011; 20(8):1299-313. PubMed ID: 21176400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.